KRTAP9-2

gene
On this page

Also known as KAP9.2

Summary

KRTAP9-2 (keratin associated protein 9-2, HGNC:16926) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 9-2 (Q9BYQ4). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….

This protein is a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This protein is a member of the ultrahigh sulfur KAP family and the gene is localized to a cluster of KAPs at 17q12-q21.

Source: NCBI Gene 83899 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 43 total
  • MANE Select transcript: NM_031961

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16926
Approved symbolKRTAP9-2
Namekeratin associated protein 9-2
Location17q21.2
Locus typegene with protein product
StatusApproved
AliasesKAP9.2
Ensembl geneENSG00000239886
Ensembl biotypeprotein_coding
Entrez83899

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000377721

RefSeq mRNA: 1 — MANE Select: NM_031961 NM_031961

CCDS: CCDS32651

Canonical transcript exons

ENST00000377721 — 1 exons

ExonStartEnd
ENSE000014749404122664841227652

Expression profiles

Bgee: expression breadth broad, 21 present calls, max score 39.14.

Top tissues by expression

119 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
skin of abdomenUBERON:000141639.14gold quality
colonic epitheliumUBERON:000039737.20gold quality
zone of skinUBERON:000001436.95gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
skin of legUBERON:000151135.69gold quality
ganglionic eminenceUBERON:000402335.49gold quality
right lungUBERON:000216733.62gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
muscle tissueUBERON:000238531.06gold quality
sural nerveUBERON:001548830.93gold quality
liverUBERON:000210730.57gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.04gold quality
right lobe of liverUBERON:000111428.89gold quality
duodenumUBERON:000211428.14gold quality
muscle of legUBERON:000138328.10gold quality
urinary bladderUBERON:000125527.95silver quality
gastrocnemiusUBERON:000138827.60gold quality
lymph nodeUBERON:000002927.57gold quality
primary visual cortexUBERON:000243627.28gold quality
tonsilUBERON:000237227.05gold quality
islet of LangerhansUBERON:000000626.55gold quality
leukocyteCL:000073826.43gold quality
vermiform appendixUBERON:000115426.42gold quality
monocyteCL:000057626.32gold quality
gall bladderUBERON:000211025.98gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.06

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

46 targeting KRTAP9-2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-314899.9775.066478
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-570-3P99.9672.414910
HSA-MIR-651-3P99.9473.485177
HSA-MIR-381-3P99.9371.872854
HSA-MIR-30099.9271.762856
HSA-MIR-16-5P99.9072.802780
HSA-MIR-494-3P99.7071.452795
HSA-MIR-518A-5P99.7069.012209
HSA-MIR-52799.7069.012209
HSA-MIR-7154-5P99.6970.521900
HSA-MIR-580-3P99.6769.231841
HSA-MIR-6832-5P99.5864.821132
HSA-MIR-1212399.5271.792990
HSA-MIR-4761-5P99.5166.69804
HSA-MIR-312399.4767.152693
HSA-MIR-239299.4367.50708
HSA-MIR-431199.3170.473041
HSA-MIR-892C-5P99.1670.562116
HSA-MIR-6510-5P99.1466.591081
HSA-MIR-92299.0267.231838
HSA-MIR-3619-5P99.0068.872308
HSA-MIR-876-3P98.7668.23945
HSA-MIR-214-3P98.7168.122128
HSA-MIR-76198.7168.072051
HSA-MIR-6894-5P98.7063.78809
HSA-MIR-3928-5P98.5067.48980
HSA-MIR-6806-3P98.5067.31980
HSA-MIR-541-5P98.2467.771181

Cross-species orthologs

0 orthologs

Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP2-1 (ENSG00000212725), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)

Protein

Protein identifiers

Keratin-associated protein 9-2Q9BYQ4 (reviewed: Q9BYQ4)

Alternative names: Keratin-associated protein 9.2, Ultrahigh sulfur keratin-associated protein 9.2

All UniProt accessions (1): Q9BYQ4

UniProt curated annotations — full annotation on UniProt →

Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.

Subunit / interactions. Interacts with hair keratins.

Similarity. Belongs to the KRTAP type 9 family.

RefSeq proteins (1): NP_114167* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002494KAPFamily

Pfam: PF13885

UniProt features (21 total): repeat 17, sequence variant 2, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BYQ4-F137.550.00

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-1266738Developmental Biology

MSigDB gene sets: 25 (showing top): TATA_C, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, TCANNTGAY_SREBP1_01, PEDRIOLI_MIR31_TARGETS_UP, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MIR570_3P, MIR494_3P, MIR892C_5P, MIR3123, TATA_01, MIR597_3P

GO Biological Process (0):

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein binding1
binding1
cytoplasm1
cellular anatomical structure1
intermediate filament1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

402 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRTAP9-2KRTAP13-1Q8IUC0587
KRTAP9-2KRTAP6-1Q3LI64528
KRTAP9-2SCYGR1A0A286YEY9527
KRTAP9-2KRT27Q7Z3Y8526
KRTAP9-2KRTAP13-2Q52LG2524
KRTAP9-2KRTAP20-1Q3LI63507
KRTAP9-2KRTAP19-3Q7Z4W3503
KRTAP9-2A8MUN0A8MUN0502
KRTAP9-2KRTAP1-4P0C5Y4480
KRTAP9-2KRT39Q6A163479
KRTAP9-2KRTAP19-2Q3LHN2476
KRTAP9-2KRTAP13-3Q3SY46468
KRTAP9-2KRTAP3-1Q9BYR8447
KRTAP9-2ZNF468Q5VIY5444
KRTAP9-2KRTAP6-3Q3LI67414

IntAct

656 interactions, top by confidence:

ABTypeScore
LCE1BKRTAP9-2psi-mi:“MI:0915”(physical association)0.790
KRTAP9-2LCE1Bpsi-mi:“MI:0915”(physical association)0.790
KRTAP10-9KRTAP9-2psi-mi:“MI:0915”(physical association)0.740
LCE4AKRTAP9-2psi-mi:“MI:0915”(physical association)0.740
KRTAP9-2KRTAP10-9psi-mi:“MI:0915”(physical association)0.740
KRTAP9-2LCE4Apsi-mi:“MI:0915”(physical association)0.740
KRTAP9-2PRKAB2psi-mi:“MI:0915”(physical association)0.720
KRTAP9-2HOXA1psi-mi:“MI:0915”(physical association)0.720
KRTAP9-2KRTAP10-11psi-mi:“MI:0915”(physical association)0.720
CREB5KRTAP9-2psi-mi:“MI:0915”(physical association)0.720
JOSD1KRTAP9-2psi-mi:“MI:0915”(physical association)0.720
LCE3EKRTAP9-2psi-mi:“MI:0915”(physical association)0.720
LCE2AKRTAP9-2psi-mi:“MI:0915”(physical association)0.720
KRTAP5-6KRTAP9-2psi-mi:“MI:0915”(physical association)0.720
KRTAP9-2CATSPER1psi-mi:“MI:0915”(physical association)0.720
KRTAP9-2PTPMT1psi-mi:“MI:0915”(physical association)0.720
NTAQ1KRTAP9-2psi-mi:“MI:0915”(physical association)0.720
NUFIP2KRTAP9-2psi-mi:“MI:0915”(physical association)0.720
KRTAP9-2GLRX3psi-mi:“MI:0915”(physical association)0.720
KRTAP5-9KRTAP9-2psi-mi:“MI:0915”(physical association)0.720
OTX1KRTAP9-2psi-mi:“MI:0915”(physical association)0.720
SMCPKRTAP9-2psi-mi:“MI:0915”(physical association)0.720

BioGRID (183): KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid), KRTAP9-2 (Two-hybrid)

ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2

Diamond homologs: A5A6P5, Q9BYP9, Q9BYQ0, Q9BYQ2, Q9BYQ3, Q9BYQ4, A8MVA2, A8MTY7

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization2024.8×2e-21
Formation of the cornified envelope815.6×2e-06

GO biological processes:

GO termPartnersFoldFDR
keratinization732.8×6e-07

Disease & clinical

Clinical variants and AI predictions

ClinVar

43 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance43
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

239 predictions. Top by Δscore:

VariantEffectΔscore
17:41227378:A:AGacceptor_gain0.8300
17:41227384:T:TAacceptor_gain0.8300
17:41227379:C:Gacceptor_gain0.8000
17:41227310:T:Gacceptor_gain0.7900
17:41227376:A:AGacceptor_gain0.7800
17:41227475:G:GTdonor_gain0.7600
17:41227385:G:Aacceptor_gain0.7300
17:41227378:ACCTT:Aacceptor_gain0.7200
17:41227339:G:Tdonor_gain0.6800
17:41226726:G:GTdonor_gain0.6600
17:41227377:C:Gacceptor_gain0.6400
17:41227448:TC:Tdonor_gain0.6300
17:41227338:G:GTdonor_gain0.6100
17:41227466:GCTTC:Gdonor_gain0.6100
17:41227415:GTT:Gdonor_gain0.6000
17:41227416:TTT:Tdonor_gain0.6000
17:41227529:A:AGacceptor_gain0.6000
17:41227382:T:Aacceptor_gain0.5900
17:41227408:TTCTC:Tdonor_gain0.5900
17:41227470:C:Gdonor_gain0.5900
17:41227479:T:TGdonor_gain0.5900
17:41226836:GCT:Gdonor_gain0.5600
17:41227479:T:Gdonor_gain0.5500
17:41227107:G:GTdonor_gain0.5400
17:41227572:T:Gacceptor_gain0.5400
17:41226926:G:GGdonor_gain0.5300
17:41227122:G:GTdonor_gain0.5300
17:41227470:C:CGdonor_gain0.5300
17:41227487:C:Gdonor_gain0.5300
17:41227571:AT:Aacceptor_gain0.5300

AlphaMissense

1147 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:41227012:T:CC120R0.754
17:41227008:A:CR118S0.743
17:41227008:A:TR118S0.743
17:41227014:C:GC120W0.700
17:41227015:T:GY121D0.699
17:41227002:C:GC116W0.675
17:41226874:A:CS74R0.652
17:41226876:C:AS74R0.652
17:41226876:C:GS74R0.652
17:41227000:T:CC116R0.627
17:41226790:A:CS46R0.621
17:41226792:C:AS46R0.621
17:41226792:C:GS46R0.621
17:41227132:T:CF160L0.621
17:41227134:C:AF160L0.621
17:41227134:C:GF160L0.621
17:41227045:T:CC131R0.611
17:41227012:T:AC120S0.598
17:41227013:G:CC120S0.598
17:41227013:G:AC120Y0.589
17:41227015:T:CY121H0.577
17:41227047:C:GC131W0.577
17:41227176:C:GC174W0.575
17:41227022:C:AP123H0.568

dbSNP variants (sampled 300 via entrez): RS1000295991 (17:41238395 G>A), RS1000453506 (17:41224716 T>C), RS1000588471 (17:41224956 C>G), RS1000856489 (17:41225567 T>G), RS1001119976 (17:41238249 C>G,T), RS1001857195 (17:41226893 G>A), RS1002262875 (17:41226126 T>C), RS1002636836 (17:41237687 G>A,C), RS1003098964 (17:41237467 A>G), RS1003748641 (17:41237370 G>A), RS1004344091 (17:41226093 T>G), RS1004822199 (17:41225772 G>A), RS1005086492 (17:41226981 C>T), RS1006037565 (17:41237901 G>A,T), RS1006294509 (17:41228055 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1decreases methylation1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.